Signet Financial Management LLC reduced its stake in AbbVie Inc. by 39.2% in the third quarter, selling 16,186 shares and holding 25,094 shares valued at $5.81 million. Despite this, other institutional investors either bought new positions or adjusted their holdings. AbbVie (NYSE:ABBV) currently holds a “Moderate Buy” consensus rating from analysts with an average target price of $251.56, and recently reported strong quarterly earnings and revenue exceeding expectations.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Signet Financial Management LLC Cuts Stake in AbbVie Inc. $ABBV
Signet Financial Management LLC reduced its stake in AbbVie Inc. by 39.2% in the third quarter, selling 16,186 shares and holding 25,094 shares valued at $5.81 million. Despite this, other institutional investors either bought new positions or adjusted their holdings. AbbVie (NYSE:ABBV) currently holds a “Moderate Buy” consensus rating from analysts with an average target price of $251.56, and recently reported strong quarterly earnings and revenue exceeding expectations.